Correction: Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients

• Lisa Zimmer,
• Serigne Lo,
• Caroline Robert,
• John Haanen,
• Ines Pires da Silva,
• Reinhard Dummer,
• Michael Manos,
• Joanna Mangana,
• Marcus O Butler,
• Richard D Carvajal,
• Alon Vaisman,
• Christian Posch,
• F Stephen Hodi,
• Paola Queirolo,
• Axel Hauschild,
• Christian U Blank,
• Maria Grazia Vitale,
• Karijn P M Suijkerbuijk,
• Alexander M Menzies,
• Aljosja Rogiers,
• Chiara Tentori,
• Joseph M Grimes,
• Megan H Trager,
• Sharon Nahm,
• Peter Bowling,
• Neha Papneja,
• April A N Rose,
• Jessica S W Borgers,
• Severine Roy,
• Thiago Pimentel Muniz,
• Tim Cooksley,
• Jeremy Lupu,
• Samuel D Saibil,
• Michael Erdmann,
• Laura Pala,
• Ryan J Sullivan,
• Wilson H Miller Jr,
• Osama E Rahma,
• Paul C Lorigan

Affiliations

Lisa Zimmer

University Hospital Essen & German Cancer Consortium, Partner Site, Essen, Germany

Serigne Lo

Melanoma Institute Australia and University of Sydney, Sydney, New South Wales, Australia

Caroline Robert

Gustave Roussy and Paris-Saclay University, Villejuif, France

John Haanen

Netherlands Cancer Institute, Amsterdam, The Netherlands

Ines Pires da Silva

Melanoma Institute Australia and University of Sydney, Sydney, New South Wales, Australia

Reinhard Dummer

Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

Michael Manos

Dana Farber Cancer Institute, Boston, Massachusetts, USA

Joanna Mangana

Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

Marcus O Butler

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

Richard D Carvajal

Columbia University Irving Medical Center, New York City, New York, USA

Alon Vaisman

Princess Margaret Cancer Centre - University Health Network, Toronto, Ontario, Canada

Christian Posch

Technical University of Munich, German Cancer Consortium (DKTK), Munich, Germany

F Stephen Hodi

Dana Farber Cancer Institute, Boston, Massachusetts, USA

Paola Queirolo

European Institute of Oncology, Milan, Italy

Axel Hauschild

University Hospital Schleswig-Holstein, Kiel, Germany

Christian U Blank

Netherlands Cancer Institute, Amsterdam, The Netherlands

Maria Grazia Vitale

Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy

Karijn P M Suijkerbuijk

University Medical Center Utrecht, Utrecht, The Netherlands

Alexander M Menzies

Melanoma Institute Australia and University of Sydney, Sydney, New South Wales, Australia

Aljosja Rogiers

Melanoma Institute Australia and University of Sydney, Sydney, New South Wales, Australia

Chiara Tentori

FROM Fondazione per la Ricerca Ospedale Maggiore, Bergamo, Italy

Joseph M Grimes

Columbia University Irving Medical Center, New York City, New York, USA

Megan H Trager

Columbia University Irving Medical Center, New York City, New York, USA

Sharon Nahm

The Christie NHS Foundation Trust, Manchester, UK

Peter Bowling

Dana Farber Cancer Institute, Boston, Massachusetts, USA

Neha Papneja

Segal Cancer Centre Jewish General Hospital, McGill University, Montreal, Québec, Canada

April A N Rose

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

Jessica S W Borgers

Netherlands Cancer Institute, Amsterdam, The Netherlands

Severine Roy

Gustave Roussy and Paris-Saclay University, Villejuif, France

Thiago Pimentel Muniz

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

Tim Cooksley

The Christie NHS Foundation Trust, Manchester, UK

Jeremy Lupu

Gustave Roussy and Paris-Saclay University, Villejuif, France

Samuel D Saibil

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

Michael Erdmann

Comprehensive Cancer Center Erlangen – EMN, University Medical Center Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany

Laura Pala

European Institute of Oncology, Milan, Italy

Ryan J Sullivan

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA

Wilson H Miller Jr

Segal Cancer Centre Jewish General Hospital, McGill University, Montreal, Québec, Canada

Osama E Rahma

Dana Farber Cancer Institute, Boston, Massachusetts, USA

Paul C Lorigan

The Christie NHS Foundation Trust, Manchester, UK